These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Down regulation of insulin receptors. Blackard WG; Guzelian PS; Small EE Trans Am Clin Climatol Assoc; 1979; 90():94-101. PubMed ID: 229608 [No Abstract] [Full Text] [Related]
25. Polypeptide hormones: pathology and clinical aspects. Van Obberghen E Acta Histochem Suppl; 1984; 29():51-5. PubMed ID: 6425926 [No Abstract] [Full Text] [Related]
26. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Shafrir E Diabetes Metab; 1996 Apr; 22(2):122-31. PubMed ID: 8792092 [TBL] [Abstract][Full Text] [Related]
28. Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action. De Pirro R; Borboni P; Marini MA; Montemurro A; Sesti G; Lauro R J Endocrinol Invest; 1990 Dec; 13(11):951-68. PubMed ID: 2090677 [No Abstract] [Full Text] [Related]
29. Autoantibodies to insulin receptors in man: immunological determinants and mechanism of action. Kahn CR; Kasuga M; King GL; Grunfeld C Ciba Found Symp; 1982; (90):91-113. PubMed ID: 6183063 [TBL] [Abstract][Full Text] [Related]
30. Autoantibodies to the insulin receptor and insulin-resistant diabetes. Van Obberghen E; Grunfeld C; Harrison LC; Karlsson A; Muggeo M; Kahn CR Horm Res; 1982; 16(5):280-8. PubMed ID: 6757094 [TBL] [Abstract][Full Text] [Related]
31. Autoantibodies against the insulin receptor. Dissociation of the acute effects of the antibodies from the desensitization seen with prolonged exposure. Grunfeld C; Jones DS; Shigenaga JK Diabetes; 1985 Mar; 34(3):205-11. PubMed ID: 3882486 [TBL] [Abstract][Full Text] [Related]
32. Insulin resistance and diabetes, mechanism and possible intervention. Koffler M; Ramirez LC; Raskin P Diabetes Res Clin Pract; 1989 Aug; 7(2):83-98. PubMed ID: 2673710 [TBL] [Abstract][Full Text] [Related]
33. Anti-insulin receptor autoantibodies in a patient with type B insulin resistance and fasting hypoglycemia. Yamasaki H; Yamaguchi Y; Fujita N; Kato C; Kuwahara H; Yamauchi MD; Yamakawa K; Abe T; Ozaki M; Sera Y; Uotani S; Kawasaki E; Takino H; Eguchi K Acta Diabetol; 2000; 37(4):189-96. PubMed ID: 11450502 [TBL] [Abstract][Full Text] [Related]
34. Antibody against the insulin receptor causes disappearance of insulin receptors in 3T3-L1 cells: a possible explanation of antibody-induced insulin resistance. Grunfeld C Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2508-11. PubMed ID: 6371815 [TBL] [Abstract][Full Text] [Related]
35. Diet-induced obesity obstructs insulin signaling in the heart. Young LH Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H306-7. PubMed ID: 19940075 [No Abstract] [Full Text] [Related]
36. Factors that control insulin action at the receptor. Bar RS Am J Med; 1983 Jan; 74(1A):18-30. PubMed ID: 6337483 [TBL] [Abstract][Full Text] [Related]
37. Demonstration of heterogeneity of autoantibodies to insulin receptors in type B insulin resistance by isoelectric focusing. Tsushima T; Omori Y; Murakami H; Hirata Y; Shizume K Diabetes; 1989 Sep; 38(9):1090-6. PubMed ID: 2767337 [TBL] [Abstract][Full Text] [Related]
38. The cell biology of the insulin receptor. Carpentier JL Diabetologia; 1989 Sep; 32(9):627-35. PubMed ID: 2676664 [TBL] [Abstract][Full Text] [Related]
39. Obesity with insulin resistance: experimental insights. Clark MG; Rattigan S; Clark DG Lancet; 1983 Nov; 2(8361):1236-40. PubMed ID: 6139579 [No Abstract] [Full Text] [Related]
40. [Hyperinsulinism syndromes caused by insulin resistance]. Robert JJ Ann Pediatr (Paris); 1990 Mar; 37(3):143-9. PubMed ID: 2190520 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]